Julia H Chariker
Overview
Explore the profile of Julia H Chariker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engelbrecht E, Stamp B, Chew L, Sarkar O, Harter P, Waigel S, et al.
JCI Insight
. 2025 Mar;
PMID: 40048259
The sentinel lymph node (SLN) is the first lymph node encountered by a metastatic cancer cell and serves as a predictor of poor prognosis, as patients with clinically occult SLN...
2.
Woolley C, Chariker J, Rouchka E, Ford E, Hudson E, Rasche K, et al.
Immunogenetics
. 2025 Feb;
77(1):14.
PMID: 39904916
Isoform sequencing (Iso-Seq) uses long-read technology to produce highly accurate full-length reads of mRNA transcripts. Visualization of individual mRNA molecules can reveal new details of transcript variation within understudied portions...
3.
Sak M, Chariker J, Park J, Rouchka E
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596026
Multiple Sclerosis (MS) is an autoimmune neurodegenerative disease affecting approximately 3 million people globally. Despite rigorous research on MS, aspects of its development and progression remain unclear. We utilized a...
4.
Gripshover T, Treves R, Rouchka E, Chariker J, Zheng S, Hudson E, et al.
Alcohol Clin Exp Res (Hoboken)
. 2024 Nov;
49(1):106-116.
PMID: 39592394
Background: Alcohol-associated hepatitis (AH) is the clinical manifestation of alcohol-associated liver disease (ALD). AH is a complex disease encompassing the dysregulation of many cells and cell subpopulations. This study used...
5.
Sak M, Chariker J, Park J, Rouchka E
medRxiv
. 2024 Aug;
PMID: 39185521
Background: Multiple Sclerosis (MS) is an autoimmune neurodegenerative disease affecting approximately 3 million people globally. Despite rigorous research on MS, aspects of its development and progression remain unclear. Understanding molecular...
6.
Gripshover T, Wahlang B, Head K, Luo J, Bolatimi O, Smith M, et al.
Environ Health Perspect
. 2024 Apr;
132(4):47007.
PMID: 38619879
Background: Environmental pollutants, including polychlorinated biphenyls (PCBs) have been implicated in the pathogenesis of liver disease. Our group recently demonstrated that PCB126 promoted steatosis, hepatomegaly, and modulated intermediary metabolism in...
7.
Holm R, Rempala G, Choi B, Brick J, Amraotkar A, Keith R, et al.
Commun Med (Lond)
. 2024 Apr;
4(1):70.
PMID: 38594350
Background: Despite wide scale assessments, it remains unclear how large-scale severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination affected the wastewater concentration of the virus or the overall disease burden...
8.
Walter M, Montoya-Durango D, Rodriguez W, Wang Y, Zhang J, Chariker J, et al.
Front Immunol
. 2024 Feb;
15:1316228.
PMID: 38370409
Background: It is well established that females are more susceptible to the toxic effects of alcohol, although the exact mechanisms are still poorly understood. Previous studies noted that alcohol reduces...
9.
Cook D, Flannigan M, Chariker J, Hare J
Front Cell Infect Microbiol
. 2024 Jan;
13:1324091.
PMID: 38274737
Introduction: strain 17978 is an opportunistic pathogen possessing a DNA damage response (DDR) in which multiple error-prone polymerase genes are co-repressed by a UmuD homolog, UmuDAb, and the small -specific...
10.
Neupane A, Chariker J, Rouchka E
Genes (Basel)
. 2023 Dec;
14(12).
PMID: 38136947
While the role of G quadruplex (G4) structures has been identified in cancers and metabolic disorders, single nucleotide variations (SNVs) and their effect on G4s in disease contexts have not...